Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Quest Diagnostics Inc (DGX) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 13,379,152
  • Shares Outstanding, K 137,490
  • Annual Sales, $ 7,515 M
  • Annual Income, $ 645 M
  • 36-Month Beta 0.68
  • Price/Sales 1.75
  • Price/Cash Flow 14.24
  • Price/Book 2.84

Price Performance

See More
Period Period Low Period High Performance
1-Month
90.13 +7.97%
on 01/30/17
97.35 -0.04%
on 02/24/17
+5.97 (+6.54%)
since 01/24/17
3-Month
86.89 +11.99%
on 12/01/16
97.35 -0.04%
on 02/24/17
+9.49 (+10.81%)
since 11/23/16
52-Week
66.07 +47.28%
on 02/25/16
97.35 -0.04%
on 02/24/17
+31.24 (+47.28%)
since 02/24/16

Most Recent Stories

More News
Quest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable...

DGX : 97.31 (+1.78%)
Quest Diagnostics and PeaceHealth to Increase Access to Innovative, High-Value Laboratory Services in the Pacific Northwest

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and PeaceHealth, a mission-based not-for-profit healthcare system, have formed a two-part arrangement to...

DGX : 97.31 (+1.78%)
Signal Announces Results of Special Meeting

Signal Genetics, Inc. (Signal) (Nasdaq:SGNL) announced today that, based upon the final vote count certified by the independent inspector of elections for the special meeting of stockholders held February...

DGX : 97.31 (+1.78%)
SGNL : 12.30 (-15.17%)
Quest Diagnostics Partners with Veracyte for Cancer Testing

Quest Diagnostics Incorporated (DGX) has recently entered into an agreement with genomic diagnostics company Veracyte, Inc. (VCYT), for the extended access of Afirma Gene Expression Classifier (GEC).

VCYT : 7.95 (+0.76%)
DGX : 97.31 (+1.78%)
GKOS : 46.19 (+2.92%)
NEOG : 65.67 (-0.15%)
Quest Diagnostics (DGX) Tops Q4 Earnings, Offers '17 View

Quest Diagnostics' (DGX) fourth-quarter 2016 adjusted earnings per share (EPS) of $1.31 came in 4 cents ahead of the Zacks Consensus Estimate.

OSUR : 11.15 (+0.63%)
DGX : 97.31 (+1.78%)
NEOG : 65.67 (-0.15%)
CSII : 27.81 (+0.62%)
Quest Diagnostics (DGX): Tops Q4 Earnings, Sales in Line

Quest Diagnostics (DGX) earnings per share has beaten Zacks Consensus Estimate while sales were in line with the mark.

DGX : 97.31 (+1.78%)
Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2016....

DGX : 97.31 (+1.78%)
Should You Buy Quest Diagnostics (DGX) Ahead of Earnings?

Quest Diagnostics (DGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

DGX : 97.31 (+1.78%)
IBM Corp (IBM) Beats on Q4 Earnings; FY17 View Positive

International Business Machines Corp (IBM) reported fourth-quarter 2016 non-GAAP earnings of $5.01 per share, which increased 3.5% from the year-ago quarter.

DGX : 97.31 (+1.78%)
IBM : 181.35 (-0.17%)
ILMN : 160.00 (-0.63%)
GM : 36.90 (-0.94%)
Quest Diagnostics (DGX) Launches HBV Quantitative Test

Quest Diagnostics Inc. (DGX), a global provider of diagnostic information services, recently rolled out Hepatitis B Virus (HBV) Quantitative Test.

DGX : 97.31 (+1.78%)
PEN : 78.35 (-1.38%)
NEOG : 65.67 (-0.15%)
CSII : 27.81 (+0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers,...

See More

Support & Resistance

2nd Resistance Point 98.58
1st Resistance Point 97.94
Last Price 97.31
1st Support Level 96.08
2nd Support Level 94.86

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.